Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Cancer Science|July 19, 2020
Lorlatinib in previously treated anaplastic lymphoma kinase-rearranged non-small cell lung cancer: Japanese subgroup analysis of a global studyTakashi Seto, Hidetoshi Hayashi, Miyako Satouchi, et al.
Respiratory Medicine Case Reports|March 5, 2021
A case of radio-insensitive SMARCA4-deficient thoracic undifferentiated carcinoma with severe right heart failureShotaro Ito, Hajime Asahina, Naoko Yamaguchi, et al.
Thoracic Cancer|July 9, 2025
Frequency and Prognostic Impact of Local Ablation Therapy for Oligoprogression in Non-Small Cell Lung CancerDaisuke Morinaga, Jun Sakakibara-Konishi, Ryohei Kamada, et al.
Cancer Cytopathology|August 6, 2026
Feasibility of routine clinical liquid-based cytology for lung cancer compact panel testingYoshiki Shinomiya, Kanako C Hatanaka, Asami Okumura, et al.
Cancer Medicine|July 7, 2025
Midkine Promotes Tumor Growth and Attenuates the Effect of Cisplatin in Small Cell Lung CancerShotaro Ito, Jun Sakakibara-Konishi, Mineyoshi Sato, et al.
Cancer Chemotherapy and Pharmacology|June 22, 2020
A randomized phase II trial of cisplatin plus gemcitabine versus carboplatin plus gemcitabine in patients with completely resected non-small cell lung cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT0703)Shin-Ichi Fukumoto, Satoshi Oizumi, Masao Harada, et al.
Translational Lung Cancer Research|March 15, 2021
Randomized phase II trial of uracil/tegafur and cisplatin versus pemetrexed and cisplatin with concurrent thoracic radiotherapy for locally advanced unresectable stage III non-squamous non-small cell lung cancer: NJLCG1001Kana Watanabe, Yukihiro Toi, Atsushi Nakamura, et al.
Lung Cancer (Amsterdam, Netherlands)|July 24, 2018
Stereotactic body radiotherapy to treat small lung lesions clinically diagnosed as primary lung cancer by radiological examination: A prospective observational studyTetsuya Inoue, Norio Katoh, Yoichi M Ito, et al.
Cancer Chemotherapy and Pharmacology|September 15, 2017
A randomized phase II trial of erlotinib vs. S-1 as a third- or fourth-line therapy for patients with wild-type EGFR non-small cell lung cancer (HOT1002)Yasuyuki Ikezawa, Hajime Asahina, Satoshi Oizumi, et al.
The Oncologist|May 10, 2019
Analysis of DLL3 and ASCL1 in Surgically Resected Small Cell Lung Cancer (HOT1702)Megumi Furuta, Jun Sakakibara-Konishi, Hajime Kikuchi, et al.
Pageof 10